BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 32978069)

  • 1. Sporadic pregnancy loss and recurrent miscarriage.
    Devall AJ; Coomarasamy A
    Best Pract Res Clin Obstet Gynaecol; 2020 Nov; 69():30-39. PubMed ID: 32978069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence.
    Coomarasamy A; Devall AJ; Brosens JJ; Quenby S; Stephenson MD; Sierra S; Christiansen OB; Small R; Brewin J; Roberts TE; Dhillon-Smith R; Harb H; Noordali H; Papadopoulou A; Eapen A; Prior M; Di Renzo GC; Hinshaw K; Mol BW; Lumsden MA; Khalaf Y; Shennan A; Goddijn M; van Wely M; Al-Memar M; Bennett P; Bourne T; Rai R; Regan L; Gallos ID
    Am J Obstet Gynecol; 2020 Aug; 223(2):167-176. PubMed ID: 32008730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestogens and pregnancy loss.
    Carp HJA
    Climacteric; 2018 Aug; 21(4):380-384. PubMed ID: 29565684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pairwise and network meta-analysis comparing the efficacy and safety of progestogens in threatened abortion.
    Zhao H; He W; Yang Z
    Int J Gynaecol Obstet; 2022 Mar; 156(3):383-393. PubMed ID: 33864694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Progestin Club Guidelines for prevention and treatment of threatened or recurrent (habitual) miscarriage with progestogens.
    Schindler AE; Carp H; Druckmann R; Genazzani AR; Huber J; Pasqualini J; Schweppe KW; Szekeres-Bartho J
    Gynecol Endocrinol; 2015 Jun; 31(6):447-9. PubMed ID: 25976550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of progestogen for women with threatened miscarriage: a systematic review and meta-analysis.
    Li L; Zhang Y; Tan H; Bai Y; Fang F; Faramand A; Chong W; Hai Y
    BJOG; 2020 Aug; 127(9):1055-1063. PubMed ID: 32324957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials.
    Saccone G; Schoen C; Franasiak JM; Scott RT; Berghella V
    Fertil Steril; 2017 Feb; 107(2):430-438.e3. PubMed ID: 27887710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options for threatened miscarriage.
    Qureshi NS
    Maturitas; 2009 Dec; 65 Suppl 1():S35-41. PubMed ID: 19945236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dydrogesterone use in early pregnancy.
    Mirza FG; Patki A; Pexman-Fieth C
    Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestogen for treating threatened miscarriage.
    Wahabi HA; Abed Althagafi NF; Elawad M; Al Zeidan RA
    Cochrane Database Syst Rev; 2011 Mar; (3):CD005943. PubMed ID: 21412891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestogen for treating threatened miscarriage.
    Wahabi HA; Abed Althagafi NF; Elawad M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005943. PubMed ID: 17636813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progestogen for preventing miscarriage.
    Haas DM; Ramsey PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD003511. PubMed ID: 24173668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestogen for preventing miscarriage.
    Haas DM; Ramsey PS
    Cochrane Database Syst Rev; 2008 Apr; (2):CD003511. PubMed ID: 18425891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world pharmacological treatment patterns of patients with threatened miscarriage in China from 2014 to 2020: A cross-sectional analysis.
    Pang YY; Ma CL
    J Clin Pharm Ther; 2022 Feb; 47(2):228-236. PubMed ID: 34704273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dydrogesterone in threatened miscarriage: a Malaysian experience.
    Pandian RU
    Maturitas; 2009 Dec; 65 Suppl 1():S47-50. PubMed ID: 20005647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestogen for treating threatened miscarriage.
    Wahabi HA; Fayed AA; Esmaeil SA; Al Zeidan RA
    Cochrane Database Syst Rev; 2011 Dec; (12):CD005943. PubMed ID: 22161393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestogens in the prevention of miscarriage.
    Carp HJ
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):55-62. PubMed ID: 26677905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Did the NICE guideline for progesterone treatment of threatened miscarriage get it right?
    Duncan WC
    Reprod Fertil; 2022 Apr; 3(2):C4-C6. PubMed ID: 35514538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestogen for preventing miscarriage.
    Oates-Whitehead RM; Haas DM; Carrier JA
    Cochrane Database Syst Rev; 2003; (4):CD003511. PubMed ID: 14583982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study.
    Ghosh S; Chattopadhyay R; Goswami S; Chaudhury K; Chakravarty B; Ganesh A
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.